BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 27275859)

  • 21. The efficacy of PPI after endoscopic hemostasis in patients with bleeding peptic ulcer and role of Helicobacter pylori.
    Gashi Z; Joksimovic N; Dragusha G; Bakalli A
    Med Arch; 2012; 66(4):236-9. PubMed ID: 22919877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current managements and outcomes of peptic and artificial ulcer bleeding in Japan.
    Fujishiro M; Abe N; Endo M; Kawahara Y; Shimoda R; Nagata S; Homma K; Morita Y; Uedo N
    Dig Endosc; 2010 Jul; 22 Suppl 1():S9-14. PubMed ID: 20590780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intermittent vs continuous proton pump inhibitor therapy for high-risk bleeding ulcers: a systematic review and meta-analysis.
    Sachar H; Vaidya K; Laine L
    JAMA Intern Med; 2014 Nov; 174(11):1755-62. PubMed ID: 25201154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of an intravenous proton pump inhibitor after endoscopic therapy with epinephrine injection for peptic ulcer bleeding in patients with uraemia: a case-control study.
    Tseng GY; Fang CT; Lin HJ; Yang HB; Tseng GC; Wang PC; Liao PC; Cheng YT; Huang CH
    Aliment Pharmacol Ther; 2009 Aug; 30(4):406-13. PubMed ID: 19485981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Omeprazole versus ranitidine as adjunct therapy to endoscopic injection in actively bleeding ulcers: a prospective and randomized study.
    Villanueva C; Balanzó J; Torras X; Sáinz S; Soriano G; González D; Vilardell F
    Endoscopy; 1995 May; 27(4):308-12. PubMed ID: 7555936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of peptic ulcer rebleeding after scheduled second endoscopy: clinical or endoscopic factors?
    Chiu PW; Joeng HK; Choi CL; Kwong KH; Ng EK; Lam SH
    Endoscopy; 2006 Jul; 38(7):726-9. PubMed ID: 16810597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastric pH in bleeding peptic ulcer.
    Javid G; Zargar SA; U-Saif R; Khan BA; Yatoo GN; Shah AH; Gulzar GM; Sodhi JS; Khan MA
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1236-43. PubMed ID: 19682194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers.
    Lau JY; Sung JJ; Lee KK; Yung MY; Wong SK; Wu JC; Chan FK; Ng EK; You JH; Lee CW; Chan AC; Chung SC
    N Engl J Med; 2000 Aug; 343(5):310-6. PubMed ID: 10922420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk Factors Associated with Rebleeding in Patients with High Risk Peptic Ulcer Bleeding: Focusing on the Role of Second Look Endoscopy.
    Kim SB; Lee SH; Kim KO; Jang BI; Kim TN; Jeon SW; Kwon JG; Kim EY; Jung JT; Park KS; Cho KB; Kim ES; Kim HJ; Park CK; Park JB; Yang CH
    Dig Dis Sci; 2016 Feb; 61(2):517-22. PubMed ID: 26297133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomised clinical trial: high-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers.
    Chen CC; Lee JY; Fang YJ; Hsu SJ; Han ML; Tseng PH; Liou JM; Hu FC; Lin TL; Wu MS; Wang HP; Lin JT
    Aliment Pharmacol Ther; 2012 Apr; 35(8):894-903. PubMed ID: 22369682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of programmed endoscopic follow-up examinations on the rebleeding rate of gastric or duodenal peptic ulcers treated by injection therapy: a prospective, randomized controlled trial.
    Messmann H; Schaller P; Andus T; Lock G; Vogt W; Gross V; Zirngibl H; Wiedmann KH; Lingenfelser T; Bauch K; Leser HG; Schölmerich J; Holstege A
    Endoscopy; 1998 Sep; 30(7):583-9. PubMed ID: 9826134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of scheduled second therapeutic endoscopy on peptic ulcer rebleeding: a prospective randomised trial.
    Chiu PW; Lam CY; Lee SW; Kwong KH; Lam SH; Lee DT; Kwok SP
    Gut; 2003 Oct; 52(10):1403-7. PubMed ID: 12970130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous infusion of high-dose omeprazole is more effective than standard-dose omeprazole in patients with high-risk peptic ulcer bleeding: a retrospective study.
    Simon-Rudler M; Massard J; Bernard-Chabert B; DI Martino V; Ratziu V; Poynard T; Thabut D
    Aliment Pharmacol Ther; 2007 Apr; 25(8):949-54. PubMed ID: 17402999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy.
    Lin HJ; Lo WC; Lee FY; Perng CL; Tseng GY
    Arch Intern Med; 1998 Jan; 158(1):54-8. PubMed ID: 9437379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral or intravenous proton pump inhibitor in patients with peptic ulcer bleeding after successful endoscopic epinephrine injection.
    Tsai JJ; Hsu YC; Perng CL; Lin HJ
    Br J Clin Pharmacol; 2009 Mar; 67(3):326-32. PubMed ID: 19523014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epinephrine injection versus epinephrine injection and a second endoscopic method in high-risk bleeding ulcers.
    Vergara M; Bennett C; Calvet X; Gisbert JP
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD005584. PubMed ID: 25308912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous non-high-dose pantoprazole is equally effective as high-dose pantoprazole in preventing rebleeding among low risk patients with a bleeding peptic ulcer after initial endoscopic hemostasis.
    Liang CM; Lee JH; Kuo YH; Wu KL; Chiu YC; Chou YP; Hu ML; Tai WC; Chiu KW; Hu TH; Chuah SK
    BMC Gastroenterol; 2012 Mar; 12():28. PubMed ID: 22455511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial.
    Sung JJ; Barkun A; Kuipers EJ; Mössner J; Jensen DM; Stuart R; Lau JY; Ahlbom H; Kilhamn J; Lind T;
    Ann Intern Med; 2009 Apr; 150(7):455-64. PubMed ID: 19221370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Vonoprazan vs Intravenous Proton Pump Inhibitor for Prevention of High-Risk Peptic Ulcers Rebleeding After Successful Endoscopic Hemostasis: A Multicenter Randomized Noninferiority Trial.
    Geeratragool T; Kaosombatwattana U; Boonchote A; Chatthammanat S; Preechakawin N; Srichot J; Sudcharoen A; Sirisunhirun P; Termsinsuk P; Rugivarodom M; Limsrivilai J; Maneerattanaporn M; Pausawasdi N; Leelakusolvong S
    Gastroenterology; 2024 Apr; ():. PubMed ID: 38582271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bleeding peptic ulcers: the current management.
    Chiu PW
    Dig Endosc; 2010 Jul; 22 Suppl 1():S19-21. PubMed ID: 20590764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.